You are here

Home ยป Company Details

EKOS CORPORATION

Company Information
Address
22122 20TH AVE SE, STE 148
BOTHELL, WA 98021
United States
Information

UEI: N/A

# of Employees: N/A
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 11

  1. ULTRASOUND MEDIATED PERMEABILITY-DRUG DELIVERY

    Amount: $0.00

    DESCRIPTION (Verbatim from Applicant's Abstract): The goal of this project is to demonstrate the feasibility of using ultrasound to temporarily make vascular tissue and cell membranes more ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health

  2. ULTRASOUND MEDIATED PERMEABILITY-DRUG DELIVERY

    Amount: $377,609.00

    DESCRIPTION (Verbatim from Applicant's Abstract): The goal of this project is to demonstrate the feasibility of using ultrasound to temporarily make vascular tissue and cell membranes more ...

    SBIRPhase II2001Department of Health and Human Services National Institutes of Health

  3. N/A

    Amount: $0.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health

  4. N/A

    Amount: $99,815.00

    N/A

    SBIRPhase II2000Department of Health and Human Services National Institutes of Health

  5. N/A

    Amount: $813,249.00

    N/A

    SBIRPhase II1999Department of Health and Human Services

  6. N/A

    Amount: $258,740.00

    N/A

    STTRPhase II1999Department of Health and Human Services

  7. ULTRASOUND MEDIATED MEMBRANE PERMEABILITY-DRUG DELIVERY

    Amount: $99,798.00

    Not Available This phase I SBIR effort will establish the feasibility of employing neurobiologically motivated algorithms for representations of visual information as used by the brain, to detect fea ...

    SBIRPhase I1999Department of Health and Human Services

  8. IN VIVO EVALUATION OF ULTRASOUND ENHANCED LYSIS

    Amount: $737,943.00

    One method of treating occluded arteries and grafts is through the infusion of thrombolytic agents. This treatment is sometimes ineffective, remains costly, and time consuming. Tachibana and others ha ...

    SBIRPhase II1998Department of Health and Human Services

  9. MECHANISMS OF ULTRASOUND ENHANCED THROMBOLYSIS

    Amount: $99,658.00

    N/A

    STTRPhase I1998Department of Health and Human Services

  10. ULTRASOUND ASSISTED TRANSMURAL DRUG DELIVERY RESTENOSIS

    Amount: $99,835.00

    N/A

    SBIRPhase I1998Department of Health and Human Services
US Flag An Official Website of the United States Government